Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma

World Journal of Gastroenterology

Volumn 19, Issue 36, 2013, Pages 6062-6068

  Kim, Sang Won ^a   Lim, Do Hoon ^a   Ahn, Yong Chan ^a   Kim, Won Seog ^a   Kim, Seok Jin ^a   Ko, Young Hyeh ^a   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Gastric mucosa associated lymphoid tissue lymphoma; Radiation therapy; Treatment response

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIEMETIC AGENT; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESOMEPRAZOLE; OMEPRAZOLE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE FREE SURVIVAL; ENDOSCOPIC BIOPSY; EPIGASTRIC DISCOMFORT; ERADICATION THERAPY; FEMALE; FLUOROSCOPY; FOLLOW UP; GASTRIC MARGINAL ZONE LYMPHOMA; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; RADIATION DOSE; REMISSION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT RESPONSE;

GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA; RADIATION THERAPY; TREATMENT RESPONSE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTON PUMP INHIBITORS; RADIATION DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885627553     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i36.6062     Document Type: Article

References (38)

1. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53: 2515-2524 [PMID: 6424928]
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392 [PMID: 8068936]
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849 [PMID: 10577857]
4. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577 [PMID: 8102719]
5. Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 1591-1594 [PMID: 7783535 DOI: 10.1016/ S0140-6736(95)90113-2]
6. Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M, Neubauer A. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018-8024 [PMID: 16204012 DOI: 10.1200/JCO.2005.02.3903]
7. Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 Suppl 5: v175-v176 [PMID: 20555074 DOI: 10.1093/annonc/mdq182]
8. Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240: 28-37 [PMID: 15213615 DOI: 10.1097/01. sla.0000129356.81281.0c]
9. Montalbán C, Castrillo JM, Abraira V, Serrano M, Bellas C, Piris MA, Carrion R, Cruz MA, Laraña JG, Menarguez J. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6: 355-362 [PMID: 7619750]
10. Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P, Coiffier B. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15: 1624-1630 [PMID: 9193362]
11. Park W, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO. Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys 2004; 58: 1480-1486 [PMID: 15050327 DOI: 10.1016/j.ijrobp.2003.09.002]
12. Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM, Mauch PM. Treatment outcome of mucosaassociated lymphoid tissue/marginal zone non-Hodgkin' s lymphoma. Int J Radiat Oncol Biol Phys 2002; 52: 1058-1066 [PMID: 11958902 DOI: 10.1016/S0360-3016(01)02714-6]
13. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ. Localized mucosaassociated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-4164 [PMID: 14615444 DOI: 10.1200/JCO.2003.06.085]
14. Tsai HK, Li S, Ng AK, Silver B, Stevenson MA, Mauch PM. Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma. Ann Oncol 2007; 18: 672-678 [PMID: 17218489 DOI: 10.1093/annonc/mdl468]
15. Yamashita H, Nakagawa K, Asari T, Murakami N, Igaki H, Ohtomo K. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 2008; 87: 412-417 [PMID: 18423914 DOI: 10.1016/ j.radonc.2008.03.012]
16. Tomita N, Kodaira T, Tachibana H, Nakamura T, Mizoguchi N, Takada A. Favorable outcomes of radiotherapy for earlystage mucosa-associated lymphoid tissue lymphoma. Radiother Oncol 2009; 90: 231-235 [PMID: 19135751 DOI: 10.1016/ j.radonc.2008.12.004]
17. Goda JS, Gospodarowicz M, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Tsang RW. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 2010; 116: 3815-3824 [PMID: 20564130 DOI: 10.1002/cncr.25226]
18. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 1916-1921 [PMID: 9586910]
19. Park HC, Park W, Hahn JS, Kim CB, Lee YC, Noh JK, Suh CO. Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone. Yonsei Med J 2002; 43: 601-606 [PMID: 12402372]
20. Lee SK, Lee YC, Chung JB, Chon CY, Moon YM, Kang JK, Park IS, Suh CO, Yang WI. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol 2004; 10: 223-226 [PMID: 14716827]
21. Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 2006; 11: 86-95 [PMID: 16579838 DOI: 10.1111/j.1523-5378.2006.00382. x]
22. Sugimoto M, Kajimura M, Shirai N, Furuta T, Kanaoka S, Ikuma M, Sato Y, Hishida A. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Intern Med 2006; 45: 405-409 [PMID: 16617193 DOI: 10.2169/internalmedicine. 45.1473]
23. Lin ML, Wirth A, Chao M, Milner AD, DiIulio J, MacManus M, Seymour JF. Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study. Intern Med J 2007; 37: 172-180 [PMID: 17316336 DOI: 10.1111/ j.1445-5994.2006.01291.x]
24. Vrieling C, de Jong D, Boot H, de Boer JP, Wegman F, Aleman BM. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol 2008; 87: 405-411 [PMID: 18343513 DOI: 10.1016/j.radonc.2008.02.012]
25. Chung SJ, Kim JS, Kim H, Kim SG, Kim CW, Jung HC, Song IS. Long-term clinical outcome of helicobacter pylorinegative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma. J Clin Gastroenterol 2009; 43: 312-317 [PMID: 18936712 DOI: 10.1097/MCG.0b013e31816a48f8]
26. Gobbi PG, Corbella F, Valentino F, Bergonzi M, Sangalli C, Perfetti V, Corazza GR. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Ann Oncol 2009; 20: 465-468 [PMID: 19074214 DOI: 10.1093/annonc/mdn668]
27. Park HS, Kim YJ, Yang WI, Suh CO, Lee YC. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol 2010; 16: 2158-2162 [PMID: 20440857 DOI: 10.3748/wjg.v16.i17.2158]
28. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400 [PMID: 8075046]
29. Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Fléjou JF, Dordonne K, de Mascarel A, Wotherspoon AC. Proposal for a new histological grading system for posttreatment evaluation of gastric MALT lymphoma. Gut 2003; 52: 1656 [PMID: 14570741 DOI: 10.1136/gut.52.11.1656]
30. Zullo A, Hassan C, Andriani A, Cristofari F, Bassanelli C, Spinelli GP, Tomao S, Morini S. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol 2010; 27: 291-295 [PMID: 19308737 DOI: 10.1007/s12032-009-9207-y]
31. Raderer M, Streubel B, Wöhrer S, Häfner M, Chott A. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006; 55: 616-618 [PMID: 16299027 DOI: 10.1136/ gut.2005.083022]
32. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ. T(11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-1294 [PMID: 11984515 DOI: 10.1053/ gast.2002.33047]
33. Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestraux A, Wotherspoon A, Dyer MJ, Chuang SS, Dogan A, Isaacson PG, Du MQ. High incidence of t(11; 18)(q21; q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003; 101: 2547-2550 [PMID: 12517817 DOI: 10.1182/ blood-2002-10-3167]
34. Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 2000; 46: 1093-1103 [PMID: 10725618 DOI: 10.1016/ S0360-3016(99)00522-2]
35. Della Biancia C, Hunt M, Furhang E, Wu E, Yahalom J. Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys 2005; 62: 745-751 [PMID: 15936555 DOI: 10.1016/j.ijrobp.2004.10.025]
36. Copie-Bergman C, Locher C, Levy M, Chaumette MT, Haioun C, Delfau-Larue MH, Leroy K, Gaulard P, Delchier JC. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol 2005; 16: 1232-1236 [PMID: 15890667 DOI: 10.1093/annonc/mdi242]
37. Capelle LG, de Vries AC, Looman CW, Casparie MK, Boot H, Meijer GA, Kuipers EJ. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008; 44: 2470-2476 [PMID: 18707866 DOI: 10.1016/j.ejca.2008.07.005]
38. Ono S, Kato M, Takagi K, Kodaira J, Kubota K, Matsuno Y, Komatsu Y, Asaka M. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer. J Gastroenterol Hepatol 2010; 25: 804-809 [PMID: 20492338 DOI: 10.1111/j.1440-1746.2009.06204.x]